Friday
SESSION 81: MORE NEW DEVELOPMENTS IN CAROTID DISEASE, ONGOING TRIALS AND CONTROVERSIES
SESSION 81 SCHEDULE
1:00 PM - 1:05 PM Predictors Of Stroke And Death After CAS: Post-Stent Ballooning Is Bad And Proper Use Of Beta Blockers Is Good: Data From The SVS VQI
  Presenter(s):Mahmoud B. Malas, MD, MHS  
  View Slides in PDF      
1:06 PM - 1:11 PM Guidelines For Management Of Carotid Stenosis Are Outdated, Inconsistent And Flawed: It Is Time For An Overhaul And Update
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
1:12 PM - 1:17 PM How Do The SVS Guidelines For Management Of Extracranial Carotid Disease Impact On Clinical Practice: Do They Need To Be Updated
  Presenter(s):Enrico Ascher, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM What Are The Ongoing Carotid Trials (CREST-2, SPACE-2, ACST-2, ACT-1, ECST-2) Telling Us And Going To Tell Us
  Presenter(s):Alison Halliday, MS, FRCS  
  View Slides in PDF      
1:24 PM - 1:29 PM Status Of The SPACE-2 Trial: Although Patient Enrollment Has Been Stopped, What Useful Information Will It Provide
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
1:30 PM - 1:35 PM What Is Happening With CREST-2: When Will We Have Answers
  Presenter(s):Thomas G. Brott, MD / Brajesh K. Lal, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Why CREST-2 May Be A Bad Deal For CAS
  Presenter(s):Mark H. Wholey, MD  
1:42 PM - 1:47 PM Double Filtration Embolic Brain Protection During CAS Improves Outcomes: A Novel PTA Balloon With An Integrated Filter Helps To Do This: The Paladin Balloon
  Presenter(s):Ravish Sachar, MD  
  View Slides in PDF      
Moderator(s): Thomas G. Brott, MD / Mark H. Wholey, MD  
1:48 PM - 1:53 PM DEBATE: Which Carotid Stenosis Patients Are Candidates For CAS In 2015: An Interventionistís View
  Presenter(s):Klaus D. Mathias, MD  
  View Slides in PDF      
1:54 PM - 1:59 PM DEBATE: Which Carotid Stenosis Patients Are Appropriate Candidates For CAS In 2015: A Vascular Surgeonís View
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
2:00 PM - 2:05 PM What Lesion Characteristics Are Higher Risk For CAS Than CEA: How Should They Influence The Choice Of Treatment In Symptomatic And Asymptomatic Patients: Data From CREST
  Presenter(s):Wesley S. Moore, MD  
  View Slides in PDF      
2:06 PM - 2:11 PM DEBATE: Screening For Asymptomatic Carotid Stenosis (ACS) Is Justified In Some Patients: Which Ones And For What Reason
  Presenter(s):Glenn Jacobowitz, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM DEBATE: Screening For ACS Is Not Justified For Any Reason
  Presenter(s):Erich Minar, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM CEA, CAS And Best Medical Treatment (BMRx) Alone: Which Treatment For Which Patient
  Presenter(s):R. Clement Darling III, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM Early Intervention After Symptom Onset Is Safe With CEA But Not With CAS
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
2:30 PM - 2:36 PM Panel Discussion
END OF SESSION 81
previous next